Cargando…
T cell biomarkers come to the fore in cancer immunotherapy
A comprehensive study by van der Sluis et al.(1) demonstrates immunotherapeutic targeting of OX40 and PD-L1 results in enhanced tumor clearance, which is linked to the dynamic emergence of distinct subsets of CD8(+) T cells.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140386/ https://www.ncbi.nlm.nih.gov/pubmed/37001529 http://dx.doi.org/10.1016/j.xcrm.2023.100989 |
_version_ | 1785033148399091712 |
---|---|
author | Sheriff, Lozan Copland, Alastair Bending, David |
author_facet | Sheriff, Lozan Copland, Alastair Bending, David |
author_sort | Sheriff, Lozan |
collection | PubMed |
description | A comprehensive study by van der Sluis et al.(1) demonstrates immunotherapeutic targeting of OX40 and PD-L1 results in enhanced tumor clearance, which is linked to the dynamic emergence of distinct subsets of CD8(+) T cells. |
format | Online Article Text |
id | pubmed-10140386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-101403862023-04-29 T cell biomarkers come to the fore in cancer immunotherapy Sheriff, Lozan Copland, Alastair Bending, David Cell Rep Med Preview A comprehensive study by van der Sluis et al.(1) demonstrates immunotherapeutic targeting of OX40 and PD-L1 results in enhanced tumor clearance, which is linked to the dynamic emergence of distinct subsets of CD8(+) T cells. Elsevier 2023-03-30 /pmc/articles/PMC10140386/ /pubmed/37001529 http://dx.doi.org/10.1016/j.xcrm.2023.100989 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Preview Sheriff, Lozan Copland, Alastair Bending, David T cell biomarkers come to the fore in cancer immunotherapy |
title | T cell biomarkers come to the fore in cancer immunotherapy |
title_full | T cell biomarkers come to the fore in cancer immunotherapy |
title_fullStr | T cell biomarkers come to the fore in cancer immunotherapy |
title_full_unstemmed | T cell biomarkers come to the fore in cancer immunotherapy |
title_short | T cell biomarkers come to the fore in cancer immunotherapy |
title_sort | t cell biomarkers come to the fore in cancer immunotherapy |
topic | Preview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140386/ https://www.ncbi.nlm.nih.gov/pubmed/37001529 http://dx.doi.org/10.1016/j.xcrm.2023.100989 |
work_keys_str_mv | AT sherifflozan tcellbiomarkerscometotheforeincancerimmunotherapy AT coplandalastair tcellbiomarkerscometotheforeincancerimmunotherapy AT bendingdavid tcellbiomarkerscometotheforeincancerimmunotherapy |